Tumor Microenvironment and Metastasis

肿瘤微环境与转移

基本信息

项目摘要

PROJECT SUMMARY (See instructions): The Tumor Microenvironment and Metastasis Program focuses on the interactions between cancer cells and their microenvironment that are determinants of the potential of tumor cells to invade surrounding tissues, penetrate blood vessels, and ultimately enter and grow in distant tissues. Studies are directed to deciphening the signaling pathways and mechanical interactions among monocytes, macrophages, endothelial cells and carcinoma cells, and each of their supporting stroma, which contribute to the metastatic phenotype. The goals of the program are to: (1) Dissect the role the microenvironment in tumor progression and metastasis, in particular, the contribution of macrophage subpopulations to the various phases and elements of tumor progression; 2) to elucidate the molecular mechanisms of growth factor and cytokine action in regulating cell migration, dissemination, angiogenesis and invasion of distant sites by primary tumor cells; 3) to assess the role of surface molecules, such a cadherins and membrane surface oligosaccharides, in tumor progression; (4) to characterize the biochemical and structural properties of molecules that regulate cytoskeletal proteins involved in tumor cell and macrophage motility through the development of (i) fluorescent biosensors of the activity status of pathways involved in regulating cell migration in vivo and (ii) photo-switchable proteins for quantitative long-term tracking of distinct groups of cells photomarked in the primary tumor and (5) to translate these findings into correlative studies with human tissues that are predictive of metastatic potential and risk, and that identify therapeutic targets. New imaging technologies are developed in the Gruss Lipper Biophotonics Center that provides this program with unique tools that are made available to the broader AECC community through the Analytical Imaging Shared Resource. Intrinsic to the experimental approach is the development of novel mouse transgenic models with fluorescently-labeled cellular lineages. The research by members of this program is integrated by a major shared focus on breast cancer, although other tumor types are studied as well. Research in this program is supported, in part, by a program project grant which reflects, and furthers, the collaborative research of members of this program. There are currently 24 members from 11 departments, of whom 10 are new to the program, supported by 22 NCI grants ($4.1M Direct) and 18 other peer-reviewed cancer-relevant grants ($3.5M Direct). Since the last CCSG review there have been 239 cancer-relevant research papers by members of this program of which 23% represent intraprogrammatic, and 28% represent interprogrammatic publications.
肿瘤微环境和转移计划重点关注癌细胞及其微环境之间的相互作用,这些微环境是肿瘤细胞侵入周围组织,穿透血管并最终进入并在远处组织中生长的潜力的决定因素。研究旨在阐明单核细胞、巨噬细胞、内皮细胞和癌细胞及其支持基质之间的信号传导途径和机械相互作用,这有助于转移表型。该项目的目标是:(1)剖析微环境在肿瘤进展和转移中的作用,特别是巨噬细胞亚群在肿瘤进展的各个阶段和要素中的贡献;(2)阐明生长因子和细胞因子在调节细胞迁移、播散、血管生成和原发性肿瘤细胞侵袭远端部位中的分子机制; 3)评估表面分子如钙粘蛋白和膜表面寡糖在肿瘤进展中的作用;(4)通过开发(i)参与调节体内细胞迁移的途径的活性状态的荧光生物传感器和(ii)用于定量长期跟踪原发性肿瘤中光标记的不同细胞群的光开关蛋白,以及(5)将这些发现转化为预测转移潜力和风险并鉴定治疗靶点的人体组织相关研究。Gruss Lipper生物光子学中心开发了新的成像技术,为该计划提供了独特的工具,并通过分析成像共享资源向更广泛的AECC社区提供这些工具。实验方法的本质是开发具有荧光标记细胞谱系的新型小鼠转基因模型。该项目成员的研究主要集中在乳腺癌上,尽管也研究了其他肿瘤类型。该计划的研究部分得到了计划项目资助的支持,该项目资助反映并促进了该计划成员的合作研究。目前有来自11个部门的24名成员,其中10名是新加入该计划的,由22个NCI赠款(410万美元直接)和18个其他同行评审的癌症相关赠款(350万美元直接)支持。自上次CCSG审查以来,该计划成员发表了239篇癌症相关研究论文,其中23%来自计划内,28%来自计划间出版物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Israel DAVID GOLDMAN其他文献

Israel DAVID GOLDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Israel DAVID GOLDMAN', 18)}}的其他基金

Cancer Biospecimen Acquisition and Biorepository
癌症生物样本采集和生物样本库
  • 批准号:
    9122698
  • 财政年份:
    2015
  • 资助金额:
    $ 33.13万
  • 项目类别:
Stem Cells, Differation and Cancer Program
干细胞、分化和癌症项目
  • 批准号:
    8753333
  • 财政年份:
    2014
  • 资助金额:
    $ 33.13万
  • 项目类别:
Pilot Research
试点研究
  • 批准号:
    8753291
  • 财政年份:
    2013
  • 资助金额:
    $ 33.13万
  • 项目类别:
Administrative Supplements for NCI-designated Cancer Centers
NCI 指定癌症中心的行政补充
  • 批准号:
    8753282
  • 财政年份:
    2013
  • 资助金额:
    $ 33.13万
  • 项目类别:
Core Support for Cancer Center
癌症中心的核心支持
  • 批准号:
    8135903
  • 财政年份:
    2010
  • 资助金额:
    $ 33.13万
  • 项目类别:
Core Support for Cancer Center
癌症中心的核心支持
  • 批准号:
    7937337
  • 财政年份:
    2009
  • 资助金额:
    $ 33.13万
  • 项目类别:
Core Support for Cancer Center
癌症中心的核心支持
  • 批准号:
    7937437
  • 财政年份:
    2009
  • 资助金额:
    $ 33.13万
  • 项目类别:
SENIOR LEADERSHIP
高层领导
  • 批准号:
    7506761
  • 财政年份:
    2007
  • 资助金额:
    $ 33.13万
  • 项目类别:
DEVELOPMENTAL FUNDS
发展基金
  • 批准号:
    7506782
  • 财政年份:
    2007
  • 资助金额:
    $ 33.13万
  • 项目类别:
PLANNING & EVALUATION
规划
  • 批准号:
    7506781
  • 财政年份:
    2007
  • 资助金额:
    $ 33.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了